These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35748638)

  • 21. Early public adherence with and support for stay-at-home COVID-19 mitigation strategies despite adverse life impact: a transnational cross-sectional survey study in the United States and Australia.
    Czeisler MÉ; Howard ME; Robbins R; Barger LK; Facer-Childs ER; Rajaratnam SMW; Czeisler CA
    BMC Public Health; 2021 Mar; 21(1):503. PubMed ID: 33722226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterizing the Spatiotemporal Heterogeneity of the COVID-19 Vaccination Landscape.
    Tiu A; Susswein Z; Merritt A; Bansal S
    Am J Epidemiol; 2022 Sep; 191(10):1792-1802. PubMed ID: 35475891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 vaccine research and immunization strategies for improved control of the COVID-19 pandemic.
    Shao Y; Wu Y; Feng Y; Xu W; Xiong F; Zhang X
    Front Med; 2022 Apr; 16(2):185-195. PubMed ID: 35226300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson.
    Patel R; Kaki M; Potluri VS; Kahar P; Khanna D
    Hum Vaccin Immunother; 2022 Dec; 18(1):2002083. PubMed ID: 35130825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 Pandemic and Indigenous Representation in Public Health Data.
    Huyser KR; Horse AJY; Kuhlemeier AA; Huyser MR
    Am J Public Health; 2021 Oct; 111(S3):S208-S214. PubMed ID: 34709868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethical allocation of COVID-19 vaccine in the United States: an evaluation of competing frameworks for the current pandemic and future events.
    Lawrence C; Vick DJ; Maryon T; Kerr BJ
    J Public Health Policy; 2022 Jun; 43(2):234-250. PubMed ID: 35140363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronavirus vaccine development: from SARS and MERS to COVID-19.
    Li YD; Chi WY; Su JH; Ferrall L; Hung CF; Wu TC
    J Biomed Sci; 2020 Dec; 27(1):104. PubMed ID: 33341119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDC's COVID-19 International Vaccine Implementation and Evaluation Program and Lessons from Earlier Vaccine Introductions.
    Soeters HM; Doshi RH; Fleming M; Adegoke OJ; Ajene U; Aksnes BN; Bennett S; Blau EF; Carlton JG; Clements S; Conklin L; Dahlke M; Duca LM; Feldstein LR; Gidudu JF; Grant G; Hercules M; Igboh LS; Ishizumi A; Jacenko S; Kerr Y; Konne NM; Kulkarni S; Kumar A; Lafond KE; Lam E; Longley AT; McCarron M; Namageyo-Funa A; Ortiz N; Patel JC; Perry RT; Prybylski D; Reddi P; Salman O; Sciarratta CN; Shragai T; Siddula A; Sikare E; Tchoualeu DD; Traicoff D; Tuttle A; Victory KR; Wallace A; Ward K; Wong MKA; Zhou W; Schluter WW; Fitter DL; Mounts A; Bresee JS; Hyde TB
    Emerg Infect Dis; 2022 Dec; 28(13):S208-S216. PubMed ID: 36502382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public Commentary.
    Weitzman ER; Sherman AC; Levy O
    Clin Infect Dis; 2022 Aug; 75(Suppl 1):S46-S50. PubMed ID: 35579499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The report from ASFA COVID-19 taskforce: Considerations and prioritization on apheresis procedures during the SARS-CoV-2 coronavirus disease (COVID-19) pandemic.
    Yamada C; Hofmann JC; Witt V; Gupta GK; Winters JL;
    J Clin Apher; 2021 Dec; 36(6):878-881. PubMed ID: 34510542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper.
    Gerotziafas GT; Catalano M; Theodorou Y; Dreden PV; Marechal V; Spyropoulos AC; Carter C; Jabeen N; Harenberg J; Elalamy I; Falanga A; Fareed J; Agathaggelou P; Antic D; Antignani PL; Bosch MM; Brenner B; Chekhonin V; Colgan MP; Dimopoulos MA; Douketis J; Elnazar EA; Farkas K; Fazeli B; Fowkes G; Gu Y; Gligorov J; Ligocki MA; Indran T; Kannan M; Kantarcioglu B; Kasse AA; Konstantinidis K; Leivano F; Lewis J; Makatsariya A; Mbaye PM; Mahé I; Panovska-Stavridis I; Olinic DM; Papageorgiou C; Pecsvarady Z; Pillon S; Ramacciotti E; Abdel-Razeq H; Sabbah M; Sassi M; Schernthaner G; Siddiqui F; Shiomura J; Slama-Schwok A; Wautrecht JC; Tafur A; Taher A; Klein-Wegel P; Zhai Z; Zoubida TM;
    Thromb Haemost; 2021 Aug; 121(8):992-1007. PubMed ID: 34169495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congregational COVID-19 Conversations: Utilization of Medical-Religious Partnerships During the SARS-CoV-2 Pandemic.
    Monson K; Oluyinka M; Negro D; Hughes N; Maydan D; Iqbal S; Golden SH; Teague P; Hale WD; Galiatsatos P
    J Relig Health; 2021 Aug; 60(4):2353-2361. PubMed ID: 34032973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent review of COVID-19 management: diagnosis, treatment and vaccination.
    Chavda VP; Vuppu S; Mishra T; Kamaraj S; Patel AB; Sharma N; Chen ZS
    Pharmacol Rep; 2022 Dec; 74(6):1120-1148. PubMed ID: 36214969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges.
    Abdullahi IN; Emeribe AU; Adekola HA; Abubakar SD; Dangana A; Shuwa HA; Nwoba ST; Mustapha JO; Haruna MT; Olowookere KA; Animasaun OS; Ugwu CE; Onoja SO; Gadama AS; Mohammed M; Daneji IM; Amadu DO; Ghamba PE; Onukegbe NB; Shehu MS; Isomah C; Babayo A; Ahmad AE
    Hum Vaccin Immunother; 2021 Mar; 17(3):620-637. PubMed ID: 32936732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving Pandemic Response: Employing Mathematical Modeling to Confront Coronavirus Disease 2019.
    Biggerstaff M; Slayton RB; Johansson MA; Butler JC
    Clin Infect Dis; 2022 Mar; 74(5):913-917. PubMed ID: 34343282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of Rapid Online Surveys to Assess People's Perceptions During Infectious Disease Outbreaks: A Cross-sectional Survey on COVID-19.
    Geldsetzer P
    J Med Internet Res; 2020 Apr; 22(4):e18790. PubMed ID: 32240094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding the Public Discussion About the Centers for Disease Control and Prevention During the COVID-19 Pandemic Using Twitter Data: Text Mining Analysis Study.
    Lyu JC; Luli GK
    J Med Internet Res; 2021 Feb; 23(2):e25108. PubMed ID: 33497351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The COVID-19 pandemic: viral variants and vaccine efficacy.
    Ciotti M; Ciccozzi M; Pieri M; Bernardini S
    Crit Rev Clin Lab Sci; 2022 Jan; 59(1):66-75. PubMed ID: 34598660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.